Different skin prick test sensitization patterns do not influence the response to omalizumab in severe asthma

evidence-based strategies for wound therapy need to be implemented in order to avoid skin exposure, at least to the most frequent clinically relevant contact allergens (tertiary butyl hydroquinone, Amerchol-L101, balsam of Peru, and fragrance mix II). The allergenic potential of modern wound dressings should not be underestimated [11]. A correlation between the number of sensitizations to wound dressings and wound duration has been observed [9,11]. Patch testing of individual topical preparations and modern wound dressings should be performed when ACD is suspected in CLU/LLD/CVI patients. The impact of modern wound dressings in the induction of ACD requires further study.